Yasuo Matsubara
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Reinfusion of Malignant Ascites through an Extracorporeal Peritoneal Venous Shunt to Avoid Complications and Assess the Safety of a Denver Shunt: A Case Report.
Journal: Case reports in oncology
Published: October 31, 2024
Both Th1 and Th2 CD4 + T-Cell Lineage Infiltrations Decrease in Post-hematopoietic Stem Cell Transplantation Colon Adenoma.
Journal: Journal of gastrointestinal cancer
Published: August 06, 2024
Concentrations of Irinotecan and SN-38 in the Ascites and the Fluid Product of Cell-Free and Concentrated Ascites Reinfusion Therapy 9 Days After Administration of Irinotecan in a Patient with Gastric Cancer: A Case Report.
Journal: OncoTargets and therapy
Published: August 05, 2024
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience.
Journal: ESMO gastrointestinal oncology
Published: August 02, 2024
BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer.
Journal: ESMO gastrointestinal oncology
Published: June 03, 2024
Evaluation of clinical effects of a multidisciplinary-collaborated cancer support team for gastrointestinal cancer chemotherapy: prospective observational study protocol of M-CAST study.
Journal: BMC gastroenterology
Published: January 30, 2023
Last Updated: 09/26/2026